Dihon Acquisition Doubles Bayer’s Consumer Health Presence In China
This article was originally published in The Tan Sheet
Executive Summary
Bayer acquired its second Chinese consumer health care firm to gain market share amid the country’s OTC consolidation trend. Dihon specializes in antifungal creams and herbal drugs for women’s and traditional Chinese medicines.